Learn More
R&D Systems™ Human FGF-20 Recombinant Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Supplier: R&D Systems™ 2547FG025
Description
The Recombinant Human FGF-20 Protein is derived from E. coli. The Recombinant Human FGF-20 Protein has been validated for the following applications: Bioactivity.Specifications
Lyophilized from a 0.2 μm filtered solution in MOPS, (NH 4 ) 2 SO 4 DTT and EDTA with BSA as a carrier protein. | |
24 kDa | |
25μg | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. | |
Recombinant |
26281 | |
FGF-20 | |
E. coli-derived human FGF-20 protein Ala2-Thr211,with an N-terminal Met and a 6-His tag | |
Unconjugated | |
97%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.